Yale Rheumatology State-of-the-Art Symposium: "Pre-autoimmunity and the Prevention of Rheumatic Diseases"
LEARNING OBJECTIVES
At the conclusion of this program, the participants should be able to:
- Discuss pre-autoimmunity and the prevention of rheumatic disease
- Use innovations and advancements in the field of rheumatoid disease
- Identify at-risk individuals
- Illustrate their knowledge on treatment options
- Employ approaches to future progress
Overview
Recent progress in our understanding of the development of autoimmunity suggests the opportunity of intervening in the prodromal phase of rheumatic diseases to prevent the future onset of clinically-apparent disease, such as arthritis or other disease manifestations.
This one-day international symposium will bring thought leaders together to review the conceptual basis and available clinical data for implementing preventive strategies in rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune and rheumatic conditions. Topics will include the definition of at-risk individuals, interventions under study, and prospects for new approaches in basic scientific and clinical investigation, and for the design of therapeutic clinical trials.
Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speakers
The Coloroado Trust
Ned Calonge, MDPresident and CEOUniversity of Texas Southwestern Medical Center
Ben Chong, MDAssistant InstructorKing's College London
Andrew Cope, MD, PhDProfessor of RheumatologyCUMC/Neurological Institute of New York
Philip De Jager, MD, PhDProfessor of NeurologyUniversity of Colorado Hospital, Veterans Affairs Medical Center
Kevin Deane, MD, PhDAssociate Professor of Medicine, Division of RheumatologyUniversity of Manitoba Arthritis Centre
Dr. Hani El-Gabalawy, MD, FRCPCProfessor of Medicine and ImmunologyNIAMS Vasculitis Translational Research Program, National Institutes of Health
Peter C. Grayson, MD, MScTenure Track InvestigatorFaculty of Pharmaceutical Sciences, University of British Columbia (UBC)
Mark Harrison, PhDAssociate ProfessorOklahoma Medical Research Foundation
Judith James, MD, PhDVice President of Clinical AffairsUT Southwestern Medical Center
David Karp, MD, PhDProfessor and Chief, Rheumatic Disease DivisionPenn State MS Hershey Medical Center
Nancy Olsen, MDDepartment of RheumatologyUniversity of Rochester Medical Center
Christopher T. Ritchlin, MD, MPHProfessor of Medicine and Chief - Department of Medicine, Allergy/Immunology and Rheumatology (SMD)